Loading
Total declarations
Company
▲ Purchases (1 ops.)
▼ Sales (0 ops.)
Latest filing published 26 Jan 2024 for Rain Oncology Inc.. Read the official filing
Filing timeline
BuySaleAvanish Vellanki
Insider track record
Disclosed buys
1
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Avanish Vellanki: trading record in brief
All filings by Avanish Vellanki on record concern Rain Therapeutics Inc., in the capacity of chief executive. The record holds 4 filings, for trades running from 11 March 2022 to 26 January 2024.
Every open-market trade on record is a purchase: 1 purchase worth €54k, and no sale. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Outside the open market, there are 1 option exercise.
The latest filing, published on 26 January 2024, reports a transaction in Rain Therapeutics Inc. The most recent open-market purchase was published on 2 June 2022, 1,599 days ago. The median gap between a trade and its publication by SEC (Form 4) is 1 day. US insiders must file a Form 4 within two business days of a trade. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Avanish Vellanki
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations4 total
2,550,910 sharesCommon Stock, par value $0.001 per shareSEC:0001999371-24-000956:0
25,000 shares@ US$2.2950.6% of flowCommon StockSEC:0000899243-22-020666:0
Canonical exit: 30 Aug 2022 (T+90)
59,618 shares0Common StockSEC:0000899243-22-014885:0
14,468 shares@ US$4.0049.4% of flowCommon StockSEC:0000899243-22-011033:0
4 of 4 declarations
